Abstract: To design the frequency selective surface (FSS) with more degrees of freedom (DoFs) and incident angle stability, an improved machine learning-based inverse topological design model is ...

(RTTNews) - Hexagon AB (HEXA-B.ST), an industrial technology company, on Monday announced it has agreed to acquire Inertial Sense LLC to drive innovation and scalable growth in the autonomous and ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.

Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...

Redefining the repeating pattern in photonic crystals creates tightly confined pathways for light while preserving symmetry, offering a simple route to ultracompact and low loss light circuits.

Hexagon shares rose after the Swedish measurement-technology group said it agreed to sell its design and engineering business to Cadence Design Systems for 2.7 billion euros ($3.15 billion). Shares in ...

Cadence Design Systems, Inc. CDNS has signed a definitive agreement to acquire the Design & Engineering (D&E) division of Hexagon AB, including its renowned MSC Software business, an industry pioneer ...